The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bristol-Myers Squibb; Daiichi Sankyo
CheckMate 577: A randomized, double-blind, phase 3 study of nivolumab (Nivo) or placebo in patients (Pts) with resected lower esophageal (E) or gastroesophageal junction (GEJ) cancer.
 
Ronan Joseph Kelly
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Lilly; Novartis
Research Funding - AstraZeneca (Inst)
 
Albert C. Lockhart
Research Funding - Bayer (Inst); CTI (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Macrogenics (Inst); Millennium (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Teva (Inst); Vertex (Inst); Zenyaku Kogyo (Inst)
 
Derek J. Jonker
No Relationships to Disclose
 
Bohuslav Melichar
Honoraria - Bristol-Myers Squibb; Lilly; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; Lilly; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Thierry Andre
Honoraria - Amgen; Baxter; BAYER; Bristol-Myers Squibb; Lilly; Merck Serono; Roche/Genentech; Sanofi
Consulting or Advisory Role - Roche/Genentech
Travel, Accommodations, Expenses - Amgen; Roche/Genentech
 
Ian Chau
Honoraria - Lilly; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Lilly; Macrogenics; MSD Oncology; Sanofi
Research Funding - Janssen-Cilag (Inst); Merck Serono (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Lilly; Merck Serono; MSD; Sanofi
 
Stephen John Clarke
Consulting or Advisory Role - AstraZeneca/MedImmune; AstraZeneca/MedImmune; Bayer; Ipsen; Merck
Speakers' Bureau - Merck
 
James M. Cleary
Research Funding - Merck
Travel, Accommodations, Expenses - Roche
 
Yuichiro Doki
No Relationships to Disclose
 
Fabio Andre Franke
No Relationships to Disclose
 
Yuko Kitagawa
Honoraria - Chugai Pharma; Ethicon; Nippon Kayaku; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ajinomoto (Inst); Asahi Kasei (Inst); Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); CSL Behring (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); GlaxoSmithKline (Inst); Kaken Pharmaceutical (Inst); Kowa (Inst); Kureha (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Medtronic (Inst); Merck Serono (Inst); Nippon Kayaku (Inst); Novartis (Inst); Otsuka (Inst); Otsuka (Inst); Pfizer (Inst); Sanofi (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Taisho Toyama Pharma (Inst); Takeda (Inst); Teijin Pharma (Inst); Tsumura & Co. (Inst); Yakult Honsha (Inst)
 
Christophe Mariette
Consulting or Advisory Role - Nestlé health Science (Inst)
Research Funding - Nestle Health Science (Inst)
Travel, Accommodations, Expenses - Bard/Davol; Bard/Davol; Ethicon; Ethicon
 
Paola Catherine Montenegro
No Relationships to Disclose
 
Enrique Luis Roca
No Relationships to Disclose
 
Marika Ciprotti
No Relationships to Disclose
 
Markus Moehler
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly/ImClone; Merck Serono; MSD Oncology; Roche/Genentech; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - Amgen; Bayer; Merck Serono; Nordic Bioscience; Roche